Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT06185803
Active, not recruiting Observational

Predictors of Anterior Patellofemoral Pain After Anterior Cruciate Ligament Reconstruction

NCT06185803 · tracked via the Priya Life Science France tracker
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Phase
Observational
Started
2023-07-27
Last updated
2025-06-08

Condition(s) studied

Anterior Cruciate Ligament Reconstruction

Investigational drug(s) / intervention(s)

anterior cruciate ligament reconstruction

anterior cruciate ligament reconstruction: anterior cruciate ligament reconstruction

Study summary

Observational, ambispective, longitudinal, monocentric, open cohort study of a population of adult patients operated on for ACL reconstruction and receiving postoperative follow-up.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient aged 18 or over * Patient who has been informed of the research and does not object to data collection * Patient who has undergone or is about to undergo ACL ligamentoplasty surgery * Regularly followed-up patient for whom the data required by the protocol will be available in the medical record History of contralateral ACL rupture Exclusion Criteria: * History of associated fracture * History of multi-ligament reconstruction

Primary outcome measure(s)

  • Anterior patellofemoral pain — Month 6
    The presence of anterior patellofemoral pain at 6 months post-op was the primary endpoint of the study.

Trial sites (1)

FacilityCityRegionStatus
Clinique de la Sauvegarde Lyon France

More GCS Ramsay Santé pour l'Enseignement et la Recherche trials in France

Evaluation of Early Home Return in Patients With Enucleation of Prostate Adenoma Recruiting
Assessment of the Benefits of Psychological Care Before Anterior Cruciate Ligament Surgery of the Knee (CLIPPER) Recruiting
Therapeutic Benefits of a Motor Imaging Protocol Following Anterior Cruciate Ligament Reconstruction Surgery Starting soon
Immersive Sensory Projections for Hospitalized Patients Recruiting
Evaluation of the Fundoplicature of the Excluded Stomach Post Omega Bypass Recruiting

Other trials for the same condition

Tourniquet vs. Dual-flow Arthroscopy Sheath in Anterior Cruciate Ligament (ACL) Reconstruction Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06185803 on ClinicalTrials.gov ↗ ← All trials in France